Health Products

Taro Pharmaceuticals Inc. Product Recall (2020-07-20)

· Published by Health Canada · Official notice

Details

Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type III

Summary

Product

A. Dermovate Cream

Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

Lot or serial numberBrand nameCompaniesDIN, NPN, DIN-HIMDosage formStrength
AB28534Taro-Clobetasol Cream USP, 0.05%
Recalling Firm
Taro Pharmaceuticals Inc.
126 East Drive
Brampton
L6T 1C1
Ontario
CANADA
Marketing Authorization Holder
Taro Pharmaceuticals Inc.
126 East Drive
Brampton
L6T 1C1
Ontario
CANADA
DIN 02245523CreamClobetasol Propionate, 0.05%
AB40179Dermovate Cream
Recalling Firm
Taro Pharmaceuticals Inc.
126 East Drive
Brampton
L6T 1C1
Ontario
CANADA
Marketing Authorization Holder
Taro Pharmaceuticals Inc.
126 East Drive
Brampton
L6T 1C1
Ontario
CANADA
DIN 02213265CreamClobetasol Propionate, 0.05%

Introduction

  1. Dermovate Cream
  2. Taro-Clobetasol Cream USP, 0.05%

Reason

The content uniformity may be out of specification in the affected lots.

Depth of distribution

Wholesalers
Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime